Attendees joined this one-of-a-kind forum designed exclusively for leaders and innovators in Treg-directed therapies. We dived into intricate Treg biology with expert scientists as they unravelled Treg pathways, mechanisms of action, and explored their unique roles in the brain. Attendees connected with industry pioneers and executives from both Treg cell therapy and modulator companies driving advancements in treatments for autoimmune and inflammatory indications.

This summit uncovered cutting-edge preclinical and clinical research, aiming to streamline and accelerate the journey of autologous and allogenic cell therapies and TNFR2 and nanomedicine-based modulators, from early concept to clinical application.